Since the pioneering work of Hans Berger in 1929 introducing the utility of human electroencephanlography (EEG) in psychiatry, a considerable amount of work has been devoted to the identification of pathophysiological mechanisms of mental diseases. However, how electrophysiology may be useful in clinical psychiatric settings is still matter of debate. Here we provide a summary of current emerging data and perspectives regarding the promising utility of various EEG tools in the treatment of mental diseases.
Methods and Results
In this report we focus on new insights reported through the use of various EEG tools (quantitative EEG, QEEG; cognitive event-related potentials, ERPs) and some new EEG-based methods (Mobile Brain/Body Imaging or Artificial Intelligence algorithms) suggesting that their use might be helpful at the clinical level in the management of various forms of mental diseases.
Conclusion
Given the encouraging results highlighting how these electrophysiological tools may be used with regard to mental disorders, continued efforts to better implement these EEG tools into psychiatric clinical settings remains one of the most pressing challenges for neurophysiologists.
BergerH. Uber das Elektrenkephalogramm des Menschen. Translated and reprinted in Pierre Gloor, Hans Berger on the electroencephalogram of man. In: Electroencephalography and clinical neurophysiology (Supp. 28). Elsevier, 1969.
2.
LavoieSPolariARGoldstoneSNelsonBMcGorryPD. Staging model in psychiatry: Review of the evolution of electroencephalography abnormalities in major psychiatric disorders. Early Interv Psychiatry. 2019;13(6):1319–1328.
3.
PriceBHAdamsRDCoyleJT. Neurology and psychiatry: Closing the great divide. Neurology. 2000;54(1):8–8.
4.
UhlhaasPJSingerW. Neuronal dynamics and neuropsychiatric disorders: Toward a translational paradigm for dysfunctional large-scale networks. Neuron. 2012;75(6):963–980.
5.
GalderisiSMucciAVolpeUBoutrosN. Evidence-based medicine and electrophysiology in schizophrenia. Clin EEG Neurosci. 2009;40(2):62–77.
6.
BaşarEGüntekinBAtagünITurp GölbaşıBTülayEÖzerdemA. Brain’s alpha activity is highly reduced in euthymic bipolar disorder patients. Cog Neurodynamics. 2012;6(1):11–20.
7.
OgrimGKropotovJHestadK. The quantitative EEG theta/beta ratio in attention deficit/hyperactivity disorder and normal controls: Sensitivity, specificity, and behavioral correlates. Psychiatry Res. 2012;198(3):482–488.
8.
KajoschHGallhoferBCortenPFromLVerbanckPCampanellaS. The bimodal P300 oddball component is decreased in patients with an adjustment disorder: An event-related potentials study. Clin Neurophysiol.2016;127(10):3209–3216. DOI: 10.1016/j.clinph.2016.07.009
9.
HamiltonHKBoosAKMathalonDH. Electroencephalography and event-related potential biomarkers in individuals at clinical high risk for psychosis. Biol Psychiatry. 2020;88(4):294–303.
10.
LuckSJMathalonDHO'DonnellBF, et al.A roadmap for the development and validation of event-related potential biomarkers in schizophrenia research. Biol Psychiatry. 2011;70(1):28–34.
11.
BadrakalimuthuVRSwamirajuRde WaalH. EEG In psychiatric practice: To do or not to do?Adv Psychiatric Treat. 2011;17(2):114–121.
12.
KuhlmannJWensingG. The applications of biomarkers in early clinical drug development to improve decision-making processes. Cur Clin Pharmacol. 2006;1(2):185–191.
13.
Verdejo-GarcíaALawrenceAJClarkL. Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev. 2008;32(4):777–810.
14.
HolmesAJHollinsheadMORoffmanJLSmollerJWBucknerRL. Individual differences in cognitive control circuit anatomy link sensation seeking, impulsivity, and substance use. J Neurosci. 2016;36(14):4038–4049.
15.
CoffmanBATorrenceNMurphyT, et al.Trait sensation seeking is associated with heightened beta-band oscillatory dynamics over left ventrolateral prefrontal cortex during reward expectancy. J Affect Dis. 2021;292:67–74.
16.
SuJKuoSIAlievF, et al.The associations between polygenic risk, sensation seeking, social support, and alcohol use in adulthood. J Abnorm Psychol.2021;130(5):525–536.
17.
CadetJLBisagnoVMilroyCM. Neuropathology of substance use disorders. Acta Neuropathol.2014;127(1):91–107.
18.
LichensteinSDMancoNCopeLM, et al.Systematic review of structural and functional neuroimaging studies of cannabis use in adolescence and emerging adulthood: Evidence from 90 studies and 9441 participants. Neuropsychopharmacol. 2022;47(5):1000–1028.
19.
ChanraudSMartelliCDelainF, et al.Brain morphometry and cognitive performance in detoxified alcohol-dependents with preserved psychosocial functioning. Neuropsychopharmacol. 2007;32(2):429–438.
20.
MackeySPaulusM. Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants?Neurosci Biobehav Rev. 2013;37(3):300–316.
21.
MeluginPRNolanSOSicilianoCA. Bidirectional causality between addiction and cognitive deficits. Int Rev Neurobiol. 2021;157:371–407.
22.
KaagAMSchulteMHJJansenJM, et al.The relation between gray matter volume and the use of alcohol, tobacco, cocaine and cannabis in male polysubstance users. Drug Alc Dep. 2018;187:186–194.
23.
LawyerGBjerkanPSHammarbergA, et al.Amphetamine dependence and co-morbid alcohol abuse: Associations to brain cortical thickness. BMC Pharmacol. 2010;10(1):1–10.
24.
PenningtonDLDurazzoTCSchmidtTPAbéCMonAMeyerhoffDJ. Alcohol use disorder with and without stimulant use: Brain morphometry and its associations with cigarette smoking, cognition, and inhibitory control. PloS One. 2015;10(3):e0122505.
25.
LittelMEuserASMunafòMRFrankenIHA. Electrophysiological indices of biased cognitive processing of substance-related cues: A meta-analysis. Neurosci Biobehav Rev.2012;36(8):1803–1816.
26.
QiuZWangJ. Altered neural activities during response inhibition in adults with addiction: A voxel-wise meta-analysis. Psychol Med.2021;51(3):387–399.
27.
HoustonRJSchlienzNJ. Event-related potentials as biomarkers of behavior change mechanisms in substance use disorder treatment. Biol Psychiatry: Cog Neurosci Neuroimaging. 2018;3(1):30–40.
28.
Verdejo-GarcíaARivas-PérezCLópez-TorrecillasFPérez-GarcíaM. Differential impact of severity of drug use on frontal behavioral symptoms. Addict Behav. 2006;31(8):1373–1382.
29.
DoussetCChenutCKajoschHKornreichCCampanellaS. Comparison of neural correlates of reactive inhibition in cocaine, heroin, and polydrug users through a contextual go/No-go task using event-related potentials. Biology (Basel).2022;11(7):1029.
30.
CampanellaSSchroderEKajoschH, et al.Neurophysiological markers of cue reactivity and inhibition subtend a three-month period of complete alcohol abstinence. Clin Neurophysiol. 2020;131(2):555–565.
31.
BatscheletHMTschuemperlinRMMoggiF, et al.Neurophysiological correlates of alcohol-specific inhibition in alcohol use disorder and its association with craving and relapse. Clin Neurophysiol. 2021;132(6):1290–1301.
32.
DoussetCSchroderEIngelsA, et al.Intact error-related negativity at the start of a three-week detoxification program reflects a short-term protective factor against relapse in alcoholic patients: Some preliminary evidence from a follow-up event-related potentials study. Clin EEG Neurosci. 2022;53(4):316–325.
33.
Domínguez-CentenoIJurado-BarbaRSionA, et al.P3 component as a potential endophenotype for control inhibition in offspring of alcoholics. Alcohol Alcoholism. 2018;53(6):699–706.
34.
PetitGCimochowskaACevallosC, et al.Reduced processing of alcohol cues predicts abstinence in recently detoxified alcoholic patients in a three months follow up period: An ERP study. Behav Brain Res. 2015;282:84–94.
35.
LittelMFrankenIHA. The effects of prolonged abstinence on the processing of smoking cues: An ERP study among smokers, ex-smokers and never-smokers. J Psychopharmacol. 2007;21(8):873–882.
36.
CampanellaSSistiagaSDoussetC, et al.Abstinence in recently detoxified AUD patients is subtended by increased inhibitory neural resources: A retrospective event-related potentials study. Int J Psychophysiol.2025;214:113203. doi:10.1016/j.ijpsycho.2025.113203
37.
BellRPFoxeJJRossLAGaravanH. Intact inhibitory control processes in abstinent drug abusers (I): A functional neuroimaging study in former cocaine addicts. Neuropharmacology. 2014;82:143–150.
38.
BelgerAYucelGHDonkersFC. In search of psychosis biomarkers in high-risk populations: Is the mismatch negativity the one we've been waiting for?Biol Psychiatry. 2012;71(2):94–95.
39.
FrancisAMSlaunwhite-HaySDempsterKJaworskaNTibboPGFisherDJ. The Complex pattern mismatch negativity as a potential indicator of psychosis across all phases of illness: A meta-analysis. Clin EEG Neurosci. 2025;56(1):72–82.
40.
NaatanenRKahkonenS. Central auditory dysfunction in schizophrenia as revealed by the mismatch negativity (MMN) and its magnetic equivalent MMNm: A review. Int J Neuropsychopharmacol. 2009;12(1):125–135.
41.
EricksonMARuffleAGoldJM. A meta-analysis of mismatch negativity in schizophrenia: From clinical risk to disease specificity and progression. Biol Psychiatry. 2016;79(12):980–987. doi: 10.1016/j.biopsych.2015.08.025
42.
AtkinsonRJMichiePTSchallU. Duration mismatch negativity and P3a in first-episode psychosis and individuals at ultra-high risk of psychosis. Biol Psychiatry. 2012;71(2):98–104.
43.
BissonnetteJNAndersonTJCrockerCETibboPGSalisburyDFFisherDJ. Examining the Complex mismatch negativity in early phase psychosis using the dual rule paradigm. Clin EEG Neurosci. 2025;56(1):91–99.
44.
RielHRudolphEDMacPheeCTibboPGFisherDJ. Reduced duration mismatch negativity elicited by the multi-feature ‘optimal’ paradigm in early-phase psychosis. Biol Psychol. 2023;180:108570.
45.
PerezVBWoodsSWRoachBJ, et al.Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: Forecasting psychosis risk with mismatch negativity. Biol Psychiatry. 2014;75(6):459–469.
46.
HaighSMCoffmanBASalisburyDF. Mismatch negativity in first-episode schizophrenia: A meta-analysis. Clin EEG Neurosci. 2017;48(1):3–10. doi: 10.1177/1550059416645980
47.
BissonnetteJNAndersonTJRossL, et al.Reduced MMN-indexed auditory change detection in a non-clinical high schizotypy sample. Personal Neurosci. 2024;7:e10.
48.
DonaldsonKRLarsenEMJonasK, et al.Mismatch negativity amplitude in first-degree relatives of individuals with psychotic disorders: Links with cognition and schizotypy. Schizophr Res. 2021;238:161–169.
49.
FisherDJLabelleAKnottVJ. The right profile: Mismatch negativity in schizophrenia with and without auditory hallucinations as measured by a multi-feature paradigm. Clin Neurophysiol. 2008;119(4):909–921.
50.
KasaiKNakagomeKItohK, et al.Impaired cortical network for preattentive detection of change in speech sounds in schizophrenia: A high-resolution event-related potential study. Am J Psychiatry. 2002;159(4):546–553.
51.
OadesRDZerbinDDittmann-BalcarAEggersC. Auditory event-related potential (ERP) and difference-wave topography in schizophrenic patients with/without active hallucinations and delusions: A comparison with young obsessive-compulsive disorder (OCD) and healthy subjects. Int J Psychophysiol. 1996;22(3):185–214.
52.
DonaldsonKRJonasKFotiDLarsenEMMohantyAKotovR. Mismatch negativity and clinical trajectories in psychotic disorders: Five-year stability and predictive utility. Psychol Med. 2023;53(12):5818–5828.
53.
LightGABraffDL. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients. Arch Gen Psychiatry. 2005;62(2):127–136.
54.
RasserPESchallUToddJ, et al.Gray matter deficits, mismatch negativity, and outcomes in schizophrenia. Schizophr Bull. 2011;37:131–140.
55.
HermensDFWardPBHodgeMAKaurMNaismithSLHickieIB. Impaired MMN/P3a complex in first-episode psychosis: Cognitive and psychosocial associations. Progr Neuropsychopharmacol Biol Psychiatry. 2010;34(6):822–829.
56.
NakajimaSHiguchiYTatenoT, et al.Duration mismatch negativity predicts remission in first-episode schizophrenia patients. Front Psychiatry. 2021;12:777378. doi:10.3389/fpsyt.2021.777378
57.
DonaldsonKRNovakKDFotiD, et al.Associations of mismatch negativity with psychotic symptoms and functioning transdiagnostically across psychotic disorders. J Abnorm Psychol. 2020;129(6):570–580.
58.
FisherDJGrantBSmithDMBorracciGLabelleAKnottVJ. Effects of auditory hallucinations on the mismatch negativity (MMN) in schizophrenia as measured by a modified ‘optimal’ multi-feature paradigm. Int J Psychophysiol. 2011;81(3):245–251.
59.
FisherDJSmithDMLabelleAKnottVJ. Attenuation of mismatch negativity (MMN) and novelty P300 in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness. Biol Psychol. 2014;100:43–49.
60.
EllsEMLRudolphEDSculthorpe-PetleyL, et al.Alterations of complex mismatch negativity (cMMN) elicited by a two-tone pattern paradigm in early-phase psychosis. Biol Psychol. 2018;135:128–135.
61.
FisherDJRudolphEDEllsEMLKnottVJLabelleATibboPG. Mismatch negativity-indexed auditory change detection of speech sounds in early and chronic schizophrenia. Psychiatry Res Neuroimaging. 2019;287:1–9.
62.
del ReECSpencerKMOribeN, et al.Clinical high risk and first episode schizophrenia: Auditory event-related potentials. Psychiatry Res. 2015;231(2):126–133.
63.
Devrim-UçokMKeskin-ErgenHYUçokA. Novelty P3 and P3b in first-episode schizophrenia and chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(8):1426–1434.
64.
EbmeierKPPotterDDCochraneRH, et al.P300 and smooth eye pursuit: Concordance of abnormalities and relation to clinical features in DSM-III schizophrenia. Acta Psychiatr Scand. 1990;82(4):283–288.
65.
JahshanCCadenheadKSRisslingAJKiriharaKBraffDLLightGA. Automatic sensory information processing abnormalities across the illness course of schizophrenia. Psychol Med. 2012;42(1):85–97.
66.
PerrottelliAGiordanoGMBrandoFGiulianiLMucciA. EEG-Based Measures in at-risk mental state and early stages of schizophrenia: A systematic review. Front Psychiatry. 2021;12:653642.
67.
TuretskyBIBilkerWBSiegelSJKohlerCGGurRE. Profile of auditory information-processing deficits in schizophrenia. Psychiatry Res. 2009;165(1–2):27–37.
68.
HorvathJWinklerIBendixenA. Do N1/MMN, P3a, and RON form a strongly coupled chain reflecting the three stages of auditory distraction?Biol Psychol. 2008;79(2):139–147.
69.
FisherDJLabelleAKnottVJ. Auditory hallucinations and the P3a: Attention-switching to speech in schizophrenia. Biol Psychol. 2010;85(3):417–423.
70.
NagaiTTadaMKiriharaK, et al.Auditory mismatch negativity and P3a in response to duration and frequency changes in the early stages of psychosis. Schizophr Res. 2013;150(2–3):547–554.
71.
RielHRudolphEMacPheeCTibboPGFisherDJ. MMN And P3a elicited by a novelty oddball paradigm are not reduced in early-phase psychosis. Neuropsychobiology. 2022;81(6):506–515.
72.
MonaghanCKBrickmanSHuynhPÖngürDHallM-H. A longitudinal study of event related potentials and correlations with psychosocial functioning and clinical features in first episode psychosis patients. Int J Psychophysiol. 2019;145:48–56.
73.
FrancisAMKnottVJLabelleAFisherDJ. Interaction of background noise and auditory hallucinations on phonemic mismatch negativity (MMN) and P3a processing in schizophrenia. Front Psychiatry. 2020;11:540738.
74.
KutasMFedermeierKD. Thirty years and counting: Finding meaning in the N400 component of the event-related brain potential (ERP). Annual Rev Psychol. 2011;62(1):621–647.
75.
KutasMFedermeierKD. Electrophysiology reveals semantic memory use in language comprehension. Trends Cog Sci. 2000;4(12):463–470.
76.
KiangMChristensenBKZipurskyRB. Depth-of-processing effects on semantic activation deficits in schizophrenia: An electrophysiological investigation. Schizophr Res. 2011;133(1-3):91–98.
77.
KiangMChristensenBKZipurskyRB. Event-related brain potential study of semantic priming in unaffected first-degree relatives of schizophrenia patients. Schizophr Res. 2014;153(1-3):78–86.
78.
McGlashanTHWalshBCWoodsSW. Structured interview for psychosis-Risk syndromes, version 5.5. PRIME Research Clinic, Yale School of Medicine; 2014.
79.
CornblattBAAutherAMNiendamT, et al.Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophr Bull. 2007;33(3):688–702.
80.
KernRSGoldJMDickinsonD, et al.The MCCB impairment profile for schizophrenia outpatients: Results from the MATRICS psychometric and standardization study. Schizophr. Res. 2011;126(1–3):124–131.
81.
OsborneKJKrausBCurranTEarlsHMittalVA. An event-related potential investigation of early visual processing deficits during face perception in youth at clinical high risk for psychosis. Schizophr Bull. 2022;48(1):90–99.
82.
KiangMGerritsenCJ. The N400 event-related brain potential response: A window on deficits in predicting meaning in schizophrenia. Int J Psychophysiol. 2019;145:65–69.
83.
BrekkeJSRaineAAnselMLenczTBirdL. Neuropsychological and psychophysiological correlates of psychosocial functioning in schizophrenia. Schizophr Bull. 1997;23(1):19–28.
84.
HoRTHFongTCTWanAHY, et al.A randomized controlled trial on the psychophysiological effects of physical exercise and Tai-chi in patients with chronic schizophrenia. Schizophr Res. 2016;171(1-3):42–49. PMC4189583.
KrakowskiMIDe SanctisPFoxeJJ, et al.Disturbances in response inhibition and emotional processing as potential pathways to violence in schizophrenia: A high-density event-related potential study. Schizophr Bull. 2016;42(4):963–974.
87.
FuSCzajkowskiNRundBRTorgalsbøenA-K. The relationship between level of cognitive impairments and functional outcome trajectories in first-episode schizophrenia. Schizophr Res. 2017;190:144–149.
88.
HelldinLMohnCOlssonA-KHjärthagF. Neurocognitive variability in schizophrenia spectrum disorders: Relationship to real-world functioning. Schizophr Res. 2020;20:100172.
89.
FalkaiPMalchowBSchmittA. Aerobic exercise and its effects on cognition in schizophrenia. Cur Op Psychiatry. 2017;30(3):171–175.
90.
FirthJCotterJElliottRFrenchPYungAR. A systematic review and meta-analysis of exercise interventions in schizophrenia patients. Psychol Med. 2015;45(7):1343–1361.
91.
MalchowBReich-ErkelenzDOertel-KnöchelV, et al.The effects of physical exercise in schizophrenia and affective disorders. Eur Arch Psychiatry Clin Neurosci. 2013;263(6):451–467.
92.
De SanctisPButlerJSGreenJMSnyderACFoxeJJ. Mobile Brain/Body Imaging (MoBI): High-density electrical mapping of inhibitory processes during walking. In: 2012 Annual international conference of the IEEE engineering in medicine and biology society: International Conference of the IEEE Engineering in Medicine and Biology Society Conference, 2012, San Diego, CA.
93.
MakeigSGramannKJungTPSejnowskiTJPoiznerH. Linking brain, mind and behavior. Int J Psychophysiol. 2009;73(2):95–100.
94.
MazurekKAPatelakiEFoxeJJFreedmanEG. Using the MoBI motion capture system to rapidly and accurately localize EEG electrodes in anatomic space. Eur J Neurosci. 2020;54(12):8396–8405.
95.
MazurekKARichardsonDAbrahamNFoxeJJFreedmanEG. Utilizing high-density electroencephalography and motion capture technology to characterize sensorimotor integration while performing complex actions. IEEE Trans Neur Syst Rehabil Eng. 2020;28(1):287–296.
96.
PatelakiEFoxeJJMcFerrenALFreedmanEG. Maintaining task performance levels under cognitive load while walking requires widespread reallocation of neural resources. Neurosci. 2023;532:113–132. PMC10842245.
97.
PatelakiEFoxeJJMazurekKAFreedmanEG. Young adults who improve performance during dual-task walking show more flexible reallocation of cognitive resources: A mobile brain-body imaging (MoBI) study. Cereb Cortex.2023;33(6):2573–2592.
98.
RichardsonDPFoxeJJFreedmanEG. Reduced proactive and reactive cognitive flexibility in older adults underlies performance costs during dual-task walking: A mobile brain/body imaging (MoBI) study. bioRxiv: the preprint server for biology, 20242024.01.27.577090.
99.
HirotaTKingBH. Autism Spectrum disorder: A review. JAMA. 2023;329(2):157.
De SanctisPSolis-EscalanteTSeeberMWagnerJFerrisDPGramannK. Time to move: Brain dynamics underlying natural action and cognition. Eur J Neurosci. 2021;54(12):8075–8080.
102.
PeskarMOmejcNŠömenMMMiladinovićAGramannKMarusicU. Stroop in motion: Neurodynamic modulation underlying interference control while sitting, standing, and walking. Biol Psychol. 2023;178:108543.
103.
BradfordJCLukosJRPassaroARiesAFerrisDP. Effect of locomotor demands on cognitive processing. Sci Rep.2019;9(1):9234.
104.
De SanctisPMalcolmBRMabiePC, et al.Mobile brain/body imaging of cognitive-motor impairment in multiple sclerosis: Deriving EEG-based neuro-markers during a dual-task walking study. Clin Neurophysiol. 2020;131(5):1119–1128.
105.
LizarragaKJPatelakiEMesmerH, et al.Mobile brain-body imaging markers of treatment-related responses in a man with Parkinson's disease. Clin Neurophysiol. 2023;152:90–92.
106.
MalcolmBRFoxeJJButlerJSDe SanctisP. The aging brain shows less flexible reallocation of cognitive resources during dual-task walking: A mobile brain/body imaging (MoBI) study. NeuroImage. 2015;117:230-2242.
107.
ProtzakJWiczorekRGramannK. Peripheral visual perception during natural overground dual-task walking in older and younger adults. Neurobiol Aging. 2021;98:146–159.
108.
EstrugoYBar YehudaSBauminger-ZvielyN. Motor, cognitive, and socio-cognitive mechanisms explaining social skills in autism and typical development. Autism Res.2024;17(11):2319–2332.
109.
Suárez-ManzanoSRuiz-ArizaAde LoureiroNEMMartínez-LópezEJ. Effects of physical activity on cognition, behavior, and motor skills in youth with autism spectrum disorder: A systematic review of intervention studies. Behavioral Sciences. 2024;14(4):330.
110.
HouYWangYDengJSongX. Effects of different exercise interventions on executive function in children with autism spectrum disorder: A network meta-analysis. Frontiers Psychiatry. 2024;15:1440123.
111.
SuWCAmonkarNCleffiCSrinivasanSBhatA. Neural effects of physical activity and movement interventions in individuals with developmental disabilities-A systematic review. Frontiers Psychiatry. 2022;13:794652.
112.
BaldessariniRJVazquezGHTondoL. Bipolar depression: A major unsolved challenge.Int J Bipolar Disord. 2020;8(1):1.
113.
KeramatianKPintoJVSchafferA, et al.Clinical and demographic factors associated with delayed diagnosis of bipolar disorder: Data from health outcomes and patient evaluations in bipolar disorder (HOPE-BD) study.J Affect Disord. 2022;296:506–513.
114.
WardenDRushAJTrivediMHFavaMWisniewskiSR. The STAR*D project results: A comprehensive review of findings.Curr Psychiatry Rep. 2007;9(6):449–459.
115.
BuschKAFawcettJJacobsDG. Clinical correlates of inpatient suicide.J Clin Psychiatry. 2003;64(1):14–19.
116.
FranklinJCRibeiroJDFoxKR, et al.Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research.Psychol Bull. 2017;143(2):187–232.
117.
Khodayari-RostamabadAReillyJPHaseyGDebruinHMaccrimmonD. Diagnosis of psychiatric disorders using EEG data and employing a statistical decision model.Annu Int Conf IEEE Eng Med Biol Soc. 2010:4006–4009.
118.
RavanMNorooziASanchezMM, et al.Diagnostic deep learning algorithms that use resting EEG to distinguish major depressive disorder, bipolar disorder, and schizophrenia from each other and from healthy volunteers.J Affect Disord. 2024;346:285–298.
119.
Khodayari-RostamabadAReillyJPHaseyGMde BruinHMaccrimmonDJ. A machine learning approach using EEG data to predict response to SSRI treatment for major depressive disorder.Clin Neurophysiol. 2013;124(10):1975–1985.
120.
MumtazWXiaLMohd YasinMAAzhar AliSSMalikAS. A wavelet-based technique to predict treatment outcome for Major depressive disorder.PLoS One. 2017;12(2):e0171409.
121.
OakleyTCoskunerJCadwalladerARavanMHaseyG. EEG Biomarkers to predict response to sertraline and placebo treatment in Major depressive disorder.IEEE Trans Biomed Eng. 2023;70(3):909–919.
122.
Khodayari-RostamabadAHaseyGMMaccrimmonDJReillyJPde BruinH. A pilot study to determine whether machine learning methodologies using pre-treatment electroencephalography can predict the symptomatic response to clozapine therapy.Clin Neurophysiol. 2010;121(12):1998–2006.
123.
RavanMHaseyGReillyJPMacCrimmonDKhodayari-RostamabadA. A machine learning approach using auditory odd-ball responses to investigate the effect of clozapine therapy.Clin Neurophysiol. 2015;126(4):721–730.
124.
HaseyG.Khodayari-RostamabadA.ReillyJ.MacCrimmonD.DeBruinH.A machine learning approach to personalized psychiatric care: prediction of antidepressant response to cognitive behaviour therapy using smart algorithms that analyze brain electrical activity patterns. In Biological psychiatry. Elsevier Science Inc, 2015, 77, 9.
125.
Khodayari-RostamabadAReillyJPHaseyGMdeBruinHMacCrimmonD. Using pre-treatment electroencephalography data to predict response to transcranial magnetic stimulation therapy for major depression.Conf Proc IEEE Eng Med Biol Soc. 2011:6418–6421.
126.
WuWZhangYJiangJ, et al.An electroencephalographic signature predicts antidepressant response in major depression.Nat Biotechnol. 2020;38(4):439–447.
127.
CohenSEZantvoordJBWezenbergBN, et al.Electroencephalography for predicting antidepressant treatment success: A systematic review and meta-analysis.J Affect Disord. 2023;321:201–207.
128.
Sanchez MMRMHaseyGReillyJMinuzziL. Diagnosing suicidal ideation from resting state EEG data using a machine learning algorithm. Conference: IEEE Engineering in Medicine and Biology Society (EMBC); 2024; Orlando, Florida.
129.
CampanellaSSchroderEKajoschHNoelXKornreichC. Why cognitive event-related potentials (ERPs) should have a role in the management of alcohol disorders. Neurosci Biobehav Rev.2019;106:234–244.
130.
CampanellaS. Use of cognitive event-related potentials in the management of psychiatric disorders: Towards an individual follow-up and multi-component clinical approach. World J Psychiatry. 2021;11(5):153.
